Ibere Pharmaceuticals
Ibere Pharmaceuticals (IBER) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IBER · as of Jun 9, 2026
Key Statistics
Explore Ibere Pharmaceuticals Data
iber stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
iber competitorsIBER
APCA
BTWN
FSNB
LCW
NFYSStock Performance
Full HistoryAbout Ibere Pharmaceuticals
Ibere Pharmaceuticals currently lacks significant operational activities, with its core mission focused on executing a business combination. This could involve a merger, an acquisition of assets or sh…
what is ibere pharmaceuticals · iber stock overview · ibere pharmaceuticals company profile · who is ibere pharmaceuticals ceo · iber NYSE · ibere pharmaceuticals headquarters · ibere pharmaceuticals business segments
About Stock Overview & Key Data
Ibere Pharmaceuticals (IBER) is a Financial Services company in the Shell Companies industry, listed on NYSE since —. As of the latest trading session, IBER stock price is $10.18, with a market capitalization of $175.6M. The stock has returned +3.77% over the past 12 months and +0.89% year-to-date.
In fiscal year 2021, Ibere Pharmaceuticals reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ibere Pharmaceuticals (IBER) stock price is $10.18. The stock is traded on NYSE under the ticker symbol IBER. The 52-week range is $9.75 – $10.75.